Roche announced new data from the Phase II FENopta study showing that investigational, oral fenebrutinib is brain penetrant and reduces brain lesions in people with relapsing multiple sclerosis (RMS) with a consistent safety profile to other fenebrutinib trials. The late-breaking data were featured in an oral presentation at the 9th Joint ECTRIMS-ACTRIMS Meeting (European and Americas Committees for Treatment and Research in Multiple Sclerosis)....
Neoss Group, a leading innovator in dental implant solutions, is proud to announce that it has received EU Medical Device Regulation (MDR) certification by its Notified Body, the BSI Group, the Netherlands B.V. for its implants and abutments. ...
SigTuple’s AI100 with ShonitTM receives U.S. FDA 510(k) Clearance...
Company Continues to Build Momentum with Most Recent Portfolio Expansion....
Patients implanted with the Evoke® System now eligible for full-body MRI scans...
A monumental step towards getting healthcare AI to augment critical care and emergency care...
Genesis MedTech, a leading medical device company, announced that its absorbable sutures with antibacterial protection have successfully obtained approval from the China's National Medical Products Administration (NMPA) for market release....
Marking a significant advancement in respiratory care...
Priyank Kharge, Minster for IT BT, Government of Karnataka speaking at the Global Innovation Alliance (GIA) Partners Meet held on August 28, 2023 in Bangalore...
Bio-Gate AG (ISIN DE000BGAG981), a leading provider of innovative technologies and individual solutions for health and hygiene, has concluded a preliminary agreement (LOI, Letter-of-Intent) with a North American medical device manufacturer focusing on the trauma sector. The medical device manufacturer intends to use Bio-Gate's "HyProtectTM " coating process for its own implants in human medicine following the FDA approval process. ...